Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Anderson BT

17 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 7 Clinical Trial 6 Review Article 5 Addiction 4 Depression 4 Anxiety 3 Observational Study 2 End-of-Life Distress 2 Mechanism of Action 2 Wellbeing 2 Spirituality 2 General 2

Journals

Journal of psychoactive drugs 5 Neuropharmacology 2 Drug and alcohol dependence 1 Journal of pain and symptom management 1 Journal of the American College of Emergency Physicians open 1 Scientific reports 1 The American journal of psychiatry 1 Journal of psychopharmacology (Oxford, England) 1

Publication history

Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.Drug and alcohol dependence · 2026-05-01 Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-03-01 Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10 US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.Journal of the American College of Emergency Physicians open · 2025-10-01 Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.Journal of psychoactive drugs · 2025-08-04 Psilocybin-assisted therapy and HIV-related shame.Scientific reports · 2024-08-02 Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.The American journal of psychiatry · 2024-01-01 Older adults in psychedelic-assisted therapy trials: A systematic review.Journal of psychopharmacology (Oxford, England) · 2024-01-01 Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2024-01-01 Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.Neuropharmacology · 2022-11-15 If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.The journal of pain · 2022-10-01 Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.Neuropharmacology · 2022-08-15 The Potential of Psychedelics for End of Life and Palliative Care.Current topics in behavioral neurosciences · 2022-01-01 Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.Journal of psychoactive drugs · 2022-01-01 Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience.ACS pharmacology & translational science · 2021-04-09 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01 Psychedelic-Assisted Group Therapy: A Systematic Review.Journal of psychoactive drugs · 2019-01-01

Author directory